Exact Mass: 331.0887622

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM and 8 nM, respectively. Zotepine exhibits antidepressive and anxiolytic effects in vivo[1][2].

7-Chloro-N-[3-(2-nitroimidazol-1-yl)propyl]quinolin-4-amine

7-chloro-N-[3-(2-nitro-1H-imidazol-1-yl)propyl]quinolin-4-amine

C15H14ClN5O2 (331.0835974)

Chlorprothixene sulfoxide

2-chloro-9-[3-(dimethylamino)propylidene]-9H-10lambda4-thioxanthen-10-one

C13H15F2N3O3S (331.08021440000005)

Didesethylflurazepam

1-(2-aminoethyl)-7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one

C17H15ClFN3O (331.0887622)

(2S,3S)-2-(2,4-Difluorophenyl)-3-methylsulfonyl-1-(1,2,4-triazol-1-yl)butan-2-ol

Threo-2-(2,4-difluorophenyl)-3-methylsulfonyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

Ggstop

2-Amino-4-((3-(carboxymethyl)phenyl)(methyl)phosphono)butanoic acid

C13H18NO7P (331.0820848)

zotepine

[2-({6-chloro-2-thiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-9-yl}oxy)ethyl]dimethylamine

C20H14ClN3 (331.08761940000005)

malvidin

C17H15O7 (331.081774)

Europinidin

3,7,3,4-Tetrahydroxy-5,5-dimethoxyflavylium

C17H15O7 (331.081774)

O1-[(3,5-Dimethylisoxazol-4-yl)carbonyl]-2-[3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanehydroximamide

C12H12F3N5O3 (331.0892198)

MY-5445

1-Phthalazinamine, N-(3-chlorophenyl)-4-phenyl-

MY-5445 is a specific inhibitor of the cyclic GMP phosphodiesterase, phosphodiesterase type 5 (PDE5), with a Ki of 1.3 μM. MY-5445 inhibits human platelet aggregation. MY-5445 is a selective modulator of ATP-binding cassette (ABC) transporter ABCG2, with anti-proliferative effect[1][2].

sanguinarine

C17H18ClN3S (331.09098980000005)

zpck

1-BENZYLOXYCARBONYLAMINOPHENETHYL CHLOROMETHYL KETONE

C18H18ClNO3 (331.0975148)

malvidin

C17H15O7+ (331.081774)

An anthocyanidin cation that is delphinidin carrying methyl substituents at positions 3 and 5.

7-chloro-4-(4-methylpiperazin-1-yl)-10H-thieno[3,2-c][1]benzazepine

CBZ-S-Phenyl-L-Cysteine

4-chlorophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside

C14H18ClNO6 (331.0822598)

4-[2-[[(4-Methylphenyl)sulfonyl]oxy]ethyl]-1,3-dihydro-2H-indole-2-one

4-(ISOCYANO(TOSYL)METHYL)-1,2-DIMETHOXYBENZENE

C15H13N3O6 (331.08043180000004)

L-Phenylalanine,N-(2,4-dinitrophenyl)-

2-(2-FLUOROACETAMIDO)-5-NITRO-N-(O-TOLYL)BENZAMIDE

C16H14FN3O4 (331.09682960000004)

1-amino-4-hydroxy-2-phenoxyanthraquinone

C16H17ClF3NO (331.09506980000003)

norfluoxetine hydrochloride

Norfluoxetine hydrochloride is an active N-demethylated metabolite of Fluoxetine. Fluoxetine is a selective serotonin (5-HT) reuptake inhibitor that is metabolized to Norfluoxetine hydrochloride by cytochrome P450 (CYP) 2D6, CYP2C19, and CYP3A4. Norfluoxetine hydrochloride inhibits 5-HT uptake and inhibits CaV3.3 T current (IC50 = 5 μM). Norfluoxetine hydrochloride has anticonvulsant activity[1][2][3][4].

1-Benzyl-7-phenyl-1H-pyrimido[4,5-d][1,3]oxazine-2,4-dione

C19H13N3O3 (331.09568680000007)

tert-butyl 4-(2,6-dichloropyridin-4-yl)piperazine-1-carboxylate

C14H19Cl2N3O2 (331.0854254)

Warfarin sodium

C19H16NaO4 (331.09462360000003)

(+-)-Benzyloxycarbonyl-alpha-phosphonoglycinetrimethylester

C13H18NO7P (331.0820848)

2-METHYL-5-PHENYL-3-(3-SULFOPROPYL)BENZOXAZOLIUM HYDROXIDE, INNER SALT

4-{5-[(2-Chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride (1:1)

C14H19Cl2N3O2 (331.0854254)

(Z)-N-[(5-Chloro-2-hydroxyphenyl)(phenyl)methylene]-L-valine

C18H18ClNO3 (331.0975148)

disperse red 60

C16H17ClF3NO (331.09506980000003)

(R)-3-PHENYL-3-(4-TRIFLUOROMETHYL-PHENOXY)-PROPYLAMINE HYDROCHLORIDE

Solvent Red 146

Chlorprothixene sulfoxide

C18H13N5S (331.08916180000006)

N-[[2-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

C16H17N3OS2 (331.0812992)

4-amino-6,7-diphenyl-2(1H)-pteridinethione

3-phenyl-4-[[4-(trifluoromethyl)anilino]methylidene]-1H-pyrazol-5-one

C17H12F3N3O (331.0932418)

2-[(Phenylsulfonyl)amino]-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid

C13H15F2N3O3S (331.08021440000005)

(2S,3S)-2-(2,4-Difluorophenyl)-3-methylsulfonyl-1-(1,2,4-triazol-1-yl)butan-2-ol

Threo-2-(2,4-difluorophenyl)-3-methylsulfonyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

Sulochrin(1-)

C17H15O7- (331.081774)

A phenolate anion that is the conjugate base of sulochrin, obtained by deprotonation of one of the phenolic hydroxy groups; major species at pH 7.3.

5-(3-chlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide

C15H14ClN5O2 (331.0835974)

4-[5-(3-Hydroxy-4-oxo-1,2-dihydroquinazolin-2-yl)-2-furanyl]benzonitrile

C19H13N3O3 (331.09568680000007)

2-[[(4-Tert-butylphenyl)-oxomethyl]amino]-4-chlorobenzoic acid

C18H18ClNO3 (331.0975148)

(9Z)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-2-ol

6-{Hydroxy[(4-nitrobenzyl)oxy]phosphoryl}hexanoic acid

C13H18NO7P (331.0820848)

4-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]butanoic acid

(3Z)-3-[(10S)-2-chloro-10-oxothioxanthen-9-ylidene]-N,N-dimethylpropan-1-amine

(9E)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-1-ol